Keyphrases
Angiotensin-converting Enzyme Inhibitor (ACEi)
18%
Blood Pressure
9%
Blood Pulse
9%
Captopril
100%
Change from Baseline
9%
Chronic Heart Failure
9%
Confidence Interval
9%
Effective Renal Plasma Flow
18%
Elderly Patients
100%
Enalapril
100%
Exercise Tolerance
9%
First Dose
9%
Gastrointestinal Diseases
9%
Glomerular Filtration Rate
45%
Group Comparison
9%
Heart Failure in Elderly
9%
Hypotension
9%
No Significant Difference
9%
Patients with Chronic Heart Failure
100%
Pressure Rate
9%
Pulse Rate
9%
Quality of Life Questionnaire
9%
Renal Function
100%
Response Rate
9%
Serious Adverse Effects
9%
Starting Treatment
9%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme
22%
Blood Pressure
11%
Captopril
100%
Effective Kidney Plasma Flow
22%
Enzyme Inhibitor
22%
Exercise Tolerance
11%
Glomerulus Filtration
55%
Kidney Function
100%
Pulse Rate
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
9%
Captopril
100%
Congestive Heart Failure
100%
Dipeptidyl Carboxypeptidase Inhibitor
18%
Enalapril
100%
Gastrointestinal Symptom
9%
Hypotension
9%